Difficulty: Medium
Average Score: 76%
Practice
Toxicities of HÔéü antihistamines include which one of the following?
Correct answer
D
Rationale
In the context of pharmacology, the correct answer to the question about the toxicities of HÔéü antihistamines being P450 inhibition is crucial to understand. Histamine is broken down by the cytochrome P450 system in the liver. Inhibiting this system can lead to drug interactions and potential toxicity from accumulation of drugs metabolized through this pathway.
Option A, blurred vision, is a common side effect of antihistamines due to their anticholinergic properties but not a direct toxicity. Option B, diarrhea, is not typically associated with HÔéü antihistamines. Option C, orthostatic hypotension, is more commonly linked to alpha-1 adrenergic blockers rather than HÔéü antihistamines.
Educationally, this question highlights the importance of understanding the specific mechanisms of action and potential side effects of different drug classes. It emphasizes the need for healthcare professionals to be aware of the potential for drug interactions and toxicities when prescribing medications that can inhibit important metabolic pathways like the cytochrome P450 system. This knowledge is essential for safe and effective pharmacological practice.
Option A, blurred vision, is a common side effect of antihistamines due to their anticholinergic properties but not a direct toxicity. Option B, diarrhea, is not typically associated with HÔéü antihistamines. Option C, orthostatic hypotension, is more commonly linked to alpha-1 adrenergic blockers rather than HÔéü antihistamines.
Educationally, this question highlights the importance of understanding the specific mechanisms of action and potential side effects of different drug classes. It emphasizes the need for healthcare professionals to be aware of the potential for drug interactions and toxicities when prescribing medications that can inhibit important metabolic pathways like the cytochrome P450 system. This knowledge is essential for safe and effective pharmacological practice.